PMC:7650537 / 5460-5971
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T39 | 107-110 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T40 | 131-139 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T41 | 256-259 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T42 | 284-292 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T43 | 389-392 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T44 | 413-416 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T30 | 96-104 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T31 | 120-128 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T32 | 296-304 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T33 | 447-455 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T38 | 140-145 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T24 | 284-292 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T40 | 0-146 | Sentence | denotes | In the following, we present data on the diagnostic performance of eight commercially available SARS-CoV-2 IgG or total SARS-CoV-2 antibody tests. |
| T41 | 147-220 | Sentence | denotes | Variations in their diagnostic sensitivity and specificity were observed. |
| T42 | 221-393 | Sentence | denotes | In terms of their performance, two IgG assays using the N or S proteins of SARS-CoV-2 were selected for an analysis of follow-up sera to obtain data on the kinetics of IgG. |
| T43 | 394-511 | Sentence | denotes | The development of IgG avidities and the kinetics of SARS-CoV-2-neutralizing antibodies were also examined over time. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 112 | 277-278 | Gene | denotes | N | Gene:43740575 |
| 113 | 282-283 | Gene | denotes | S | Gene:43740568 |
| 114 | 296-306 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 115 | 96-106 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 116 | 120-130 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 117 | 447-457 | Species | denotes | SARS-CoV-2 | Tax:2697049 |